For patients with breast cancer in one breast, many are satisfied with opting for double mastectomy
the ONA take:
According to a new study published in the journal Annals of Surgical Oncology, most women who chose to undergo double mastectomies despite having cancer in only one breast are content with their choice and would likely make the same choice again.
In the study, researchers from the Mayo Clinic in Rochester, Minnesota, surveyed 621 women with a family history of breast cancer, diagnosed with cancer in one breast, and elected to undergo a double mastectomy. Approximately 10 and 20 years after undergoing their double mastectomies, researchers asked the women about their quality of life and whether they were satisfied with their decision to have both breasts removed.
After 10 years, 83% of the 583 women that responded were satisfied with their decision and 84% would make the same decision twice. Overall, most women who had breast reconstruction were satisfied with their decisions, but women who had complications associated with breast reconstruction were more likely to regret their choice for prophylactic mastectomy.
The likelihood of developing cancer in the other breast is not that high, and oftentimes, patients' anxiety influences their choice to undergo a double mastectomy. Increased anxiety about the risk for developing cancer in the other breast may decrease quality of life.
Most women who undergo double mastectomies despite having cancer in only one breast are content.
More women with cancer in one breast are opting to have both breasts removed to reduce their risk of future cancer. New research shows that in the long term, most have no regrets. Mayo Clinic surveyed hundreds of women with breast cancer who had double mastectomies between 1960 and 1993 and found that nearly all would make the same choice again.
The findings are published in the journal Annals of Surgical Oncology. The study made a surprising finding: While most women were satisfied with their decision whether they followed it with breast reconstruction or not, patients who decided against reconstructive surgery were likelier to say they would choose to have both breasts removed again.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|